North America Microcrystalline Cellulose Market Overview:
Global North America Microcrystalline Cellulose Market size and share is currently valued at USD 597.03 million in 2024 and is anticipated to generate an estimated revenue of USD 1,058.00 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 – 2032
Key Market Drivers:
- Pharmaceutical Industry Demand: MCC is widely used as an excipient in drug formulation, driving its demand in the pharmaceutical sector.
- Food Industry Applications: The use of MCC as a fat replacer and stabilizer in low-calorie and health-focused food products supports market growth.
Download Free Sample PDF Copy of the Report:
Market Research Scope:
- Product Attributes: Purity levels, particle size variations, and applications in pharmaceuticals, food, and cosmetics.
- Regional Demand: Growth trends in the U.S., Canada, and Mexico.
- End-User Industries: Key sectors driving demand, including healthcare and food & beverage.
- Technological Advances: Production processes and novel uses of MCC.
- Market Challenges: Raw material costs and competition from alternative cellulose derivatives.
Key Companies in North America Microcrystalline Cellulose Market:
- ANDRITZ
- Apollo Scientific Ltd
- Asahi Kasei Corporation
- Azelis
- DFE Pharma
- FMC Corporation
- International Flavors & Fragrances Inc. (IFF)
- JRS PHARMA
- Roquette Frères
- SEPPIC
North America Microcrystalline Cellulose Market Segmentation:
Microcrystalline cellulose (MCC) is a versatile excipient widely used in pharmaceuticals, food, and cosmetics for its excellent binding, stabilizing, and texturizing properties. In North America, the MCC market is growing due to advancements in pharmaceutical applications, alongside increasing demand in processed food industries for clean-label ingredients. Derived from plant-based sources like wood pulp, MCC aligns with the region’s focus on sustainable and biodegradable materials. Innovations in production processes aim to improve efficiency and expand its application range in diverse sectors.
North America Microcrystalline Cellulose Market, Source Type Outlook (Revenue – USD Million, 2019-2032)
- Wood Based
- Non-Wood Based
North America Microcrystalline Cellulose Market, Form Outlook (Revenue – USD Million, 2019-2032)
- Liquid
- Powder
North America Microcrystalline Cellulose Market, Grade Outlook (Revenue – USD Million, 2019-2032)
- Grade 101
- Grade 102
- Grade 200
- Grade 301
- Grade 302
- Others
North America Microcrystalline Cellulose Market, End Use Outlook (Revenue – USD Million, 2019-2032)
- Pharmaceutical
- Food & Beverages
- Paints and Coatings
- Cosmetics & Personal Care
- Others
North America Microcrystalline Cellulose Industry Developments:
- September 2023: IFF announced the introduction of its Avicel PH LN portfolio, a premium low-nitrite microcrystalline cellulose designed to reduce the risk of nitrosamine formation in finished pharmaceutical products, catering to the stringent safety requirements of the pharmaceutical industry.
- July 2021: DFE Pharma launched Pharmacol sMCC 90, a silicified microcrystalline cellulose formulated as a synergistic solution to address challenges in oral solid dosage formulations, enhancing performance and reliability.
The North America Microcrystalline Cellulose market report offers an in-depth analysis of market dynamics, including trends, sizes, patterns, and growth factors. It highlights critical developments and emerging trends to help stakeholders refine their strategies and strengthen market positioning. The report concludes with a detailed summary of key findings and the research methodologies employed. This comprehensive analysis serves as a valuable resource for businesses, investors, and stakeholders, enabling them to make informed decisions and drive sustainable growth.